Orphan Drug Market Growth Through 2019
Research and Markets released its report Global Orphan Drugs Market 2015-2019, forecasting the market to grow at a CAGR of 10.05% over the period 2014-2019.
Research analysts noted emerging trends in the orphan drug market are a focus on biologics, shorter drug development timelines, and the challenges of enrollment. Conducting clinical trials in rare diseases with smaller number of patients available for clinical studies is around recruiting enough patients to generate significant comparative data.
Read the full
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025